Friday, March 31, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

FDA Seeks Immunoassay System for Tox Research

by Global Biodefense Staff
February 4, 2016

The FDA’s National Center for Toxicological Research (NCTR) is conducting a market survey for immunoassay systems to detect cardiac toxicity biomarkers.

Drug-induced cardiac toxicity is one of the common adverse effects which cause the FDA concern. The level of cardiac troponin I, one of the most commonly used cardiac injury biomarkers, needs to be measured to help access the severity of drug-induced cardiac injury.

One of the challenges NCTR is facing is the low level of troponin I in mouse plasma compared to human plasma. NCTR requires an Immunoassay System that can quantify the cardiac troponin I efficiently with high sensitivity in mouse plasma. The data gained from this instrument will directly help to interpret the drug treatment effect.

System capabilities must include:

  • Beaded-based, fluorescence-coupled, single-molecule counting for ultra-sensitivity and low background.
  • Low limit of detection at 0.1 picogram/milliliter for Troponin I assay.
  • Linear dynamic range of up to 4 orders of magnitude for detection.
  • High precision counting with low end average cardiovascular (CV) less than 12 percent for Troponin I assay.
  • Small volume (down to 50 microliters) needed for each assay.

Further details are available via Solicitation Number: FDA1161996. The response deadline is February 11, 2016.

Tags: Biomarkers

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC